Literature DB >> 6734700

Pharmacokinetics of cefoxitin administered by i.v. infusion to patients with a pleural effusion.

M J Otero, M J Garcia, M Barrueco, A Dominguez-Gil, F Gomez, J Portugal Alvarez.   

Abstract

The pharmacokinetics of cefoxitin was studied in 6 healthy volunteers and in 5 patients with a pleural effusion after administration of a single dose of 30 mg/kg i.v. infusion. The serum and pleural fluid concentrations of cefoxitin were determined microbiologically. The elimination half-life of the antibiotic from pleural fluid in all cases was 2-3 fold longer than from serum, which shows a difference between the kinetic elimination processes of the antibiotic from the two fluids. The slow elimination of cefoxitin from pleural fluid facilitates its accumulation in this compartment during a multiple dosage regimen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734700     DOI: 10.1007/BF00548772

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  8 in total

Review 1.  Bioavailability and pharmacokinetics of cefoxitin sodium.

Authors:  J J Schrogie; R O Davies; K C Yeh; D Rogers; G I Holmes; H Skeggs; C M Martin
Journal:  J Antimicrob Chemother       Date:  1978-07       Impact factor: 5.790

2.  Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.

Authors:  H Lode; B Kemmerich; G Gruhlke; G Dzwillo; P Koeppe; I Wagner
Journal:  J Antimicrob Chemother       Date:  1980-09       Impact factor: 5.790

3.  Penetration of cefuroxime and doxycycline into the pleural fluid.

Authors:  B Hoffstedt; B Ode; M Walder; A Hanson; P Christensson; S Cronberg
Journal:  J Antimicrob Chemother       Date:  1980-01       Impact factor: 5.790

4.  Antibiotic concentrations in human parapneumonic effusions.

Authors:  D A Taryle; J T Good; E J Morgan; L B Reller; S A Sahn
Journal:  J Antimicrob Chemother       Date:  1981-02       Impact factor: 5.790

5.  Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.

Authors:  M J Garcia; A Dominguez-Gil; J M Tabernero; J A Sanchez Tomero
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

6.  Disposition of cefoxitin in patients with ascites.

Authors:  M J Garcia; A Dominguez-Gil; F D Perez; F P Rodriguez; F D Moronta
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  The kinetics of cefuroxime in ascitic and pleural fluid.

Authors:  A Lechi; E Arosio; L Xerri; C Mengoli; G Montesi; O Ghidini
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1982-10

8.  Disposition of cefoxitin in the elderly.

Authors:  M J Garcia; A Garcia; M J Nieto; A Dominguez-Gil; G Alonso; L Mellado
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.